Abstract
Recent investigations of the cellular and molecular mechanisms of pain provide new hopes for more effective treatments for patients with chronic pain. At the molecular and genetic levels, new proteins and genes related to sensory sensation have been identified. However, many of these new discoveries have not resulted in better and more effective treatments for chronic pain. This disconnect between discovery and better treatment options is due, in part to the negative side effects associated with new treatment options, and also as a result of the ineffectiveness of these new drugs for inhibiting chronic pain. In this review, I will explore this disconnect between discovery and treatment, and propose that the failure of previous medicines can be due to their limited effects on injury-related plasticity, and question the common misperception of seeking compounds for high efficacy before understanding basic mechanisms of the target proteins in pain-related plasticity.
Keywords: Chronic pain, anterior cingulate cortex (ACC), insular cortex (IC), long-term potentiation (LTP), long-term depression (LTD), mice.
Current Pharmaceutical Design
Title:Targeting Injury-Related Synaptic Plasticity for the Treatment of Chronic Pain
Volume: 21 Issue: 7
Author(s): Min Zhuo
Affiliation:
- Department of Physiology, University of Toronto, Faculty of Medicine, Medical Science Building, Room #3342 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada.,Canada
Keywords: Chronic pain, anterior cingulate cortex (ACC), insular cortex (IC), long-term potentiation (LTP), long-term depression (LTD), mice.
Abstract: Recent investigations of the cellular and molecular mechanisms of pain provide new hopes for more effective treatments for patients with chronic pain. At the molecular and genetic levels, new proteins and genes related to sensory sensation have been identified. However, many of these new discoveries have not resulted in better and more effective treatments for chronic pain. This disconnect between discovery and better treatment options is due, in part to the negative side effects associated with new treatment options, and also as a result of the ineffectiveness of these new drugs for inhibiting chronic pain. In this review, I will explore this disconnect between discovery and treatment, and propose that the failure of previous medicines can be due to their limited effects on injury-related plasticity, and question the common misperception of seeking compounds for high efficacy before understanding basic mechanisms of the target proteins in pain-related plasticity.
Export Options
About this article
Cite this article as:
Zhuo Min, Targeting Injury-Related Synaptic Plasticity for the Treatment of Chronic Pain, Current Pharmaceutical Design 2015; 21(7) . https://dx.doi.org/10.2174/1381612820666141027124011
DOI https://dx.doi.org/10.2174/1381612820666141027124011 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Mast Cell – Glia Dialogue in Chronic Pain and Neuropathic Pain: Blood-Brain Barrier Implications
CNS & Neurological Disorders - Drug Targets Adult Stem Cell Transplantation in Stroke: Its Limitations and Prospects
Current Stem Cell Research & Therapy Effects of Melatonin on Ischemic Spinal Cord Injury Caused by Aortic Cross Clamping in Rabbits
Current Neurovascular Research Alpha-2 Adrenoceptor Ligands and Opioid Drugs: Pharmacological Interactions of Therapeutic Interest
Current Neuropharmacology Biopolymer-based Scaffolds for Tissue Engineering Applications
Current Drug Targets Lithium and its Neuroprotective and Neurotrophic Effects: Potential Treatment for Post-Ischemic Stroke Sequelae
Current Drug Targets The Role of Neurotrophins in Axonal Growth, Guidance, and Regeneration
Current Neurovascular Research From The Editors Perspective: Unlocking the Secrets to Cell Survival and Longevity
Current Neurovascular Research The Development of Stem Cell-Based Treatment for Liver Failure
Current Stem Cell Research & Therapy Nanowired Drug Delivery of Antioxidant Compound H-290/51 Enhances Neuroprotection in Hyperthermia-Induced Neurotoxicity
CNS & Neurological Disorders - Drug Targets Covalently and Ionically Crosslinked Chitosan Nanogels for Drug Delivery
Current Pharmaceutical Design Neural Induction of Adult Bone Marrow and Umbilical Cord Stem Cells
Current Neurovascular Research Utilizing Delta Opioid Receptors and Peptides for Cytoprotection: Implications in Stroke and Other Neurological Disorders
CNS & Neurological Disorders - Drug Targets Subject Index Volume 2
Current Pediatric Reviews Could Computed Tomography Hounsfield Unit Values of Lumbar Vertebrae Detect Osteoporosis?
Current Medical Imaging The ERK 1 and 2 Pathway in the Nervous System: From Basic Aspects to Possible Clinical Applications in Pain and Visceral Dysfunction
Current Neuropharmacology Mesenchymal Stem Cell-Based Therapy for the Treatment of Type 1 Diabetes Mellitus
Current Stem Cell Research & Therapy Mitochondrial Neuroprotection in Traumatic Brain Injury: Rationale and Therapeutic Strategies
CNS & Neurological Disorders - Drug Targets The Roles of Flavonols/Flavonoids in Neurodegeneration and Neuroinflammation
Mini-Reviews in Medicinal Chemistry Neurodegenerative Pathways in Alzheimer’s Disease: A Review
Current Neuropharmacology